WILMINGTON, DE / ACCESSWIRE / March 28, 2023 / Transparency Market Research Inc. - The pulmonary valve replacement market was valued at USD 1.0 Bn in 2022 and is projected to surpass USD 1.6 Bn by ...

Please provide your email address to receive an email when new articles are posted on . Edwards Lifesciences announced it received FDA approval for its transcatheter valve with adaptive prestent for ...

The US Food and Drug Administration (FDA) has cleared Edwards Lifesciences’ SAPIEN 3 transcatheter valve with the Alterra adaptive prestent for pulmonic heart valve replacement, the manufacturer ...

Off-label use of the Sapien and Sapien XT valves represents a “viable and durable option” for restoring pulmonary valve function in patients with right-ventricular outflow tract (RVOT) disorders, ...

Vancouver, Sept. 04, 2023 (GLOBE NEWSWIRE) -- The worldwide market for transcatheter pulmonary valve replacement reached a value of USD 44.62 Million in 2022. As per the most recent assessment ...

Please provide your email address to receive an email when new articles are posted on . Edwards Lifesciences Corporation announced that its transcatheter heart valve has received FDA approval for ...

Powered by SBIR grant funding, PolyVascular advances options for children in need of pulmonary valve replacement with its polymeric stent-mounted valve small enough for the tiniest patients. The ...

Device preparation for downsizing the diameter of the pulmonary trunk. We designed and developed a self-expandable stent constructed from a single 0.22-mm nitinol wire in the shape of a conduit with a ...

Pulmonary Heart Valve Replacement market players – Edwards Lifesciences Corporation, Boston Scientific Corporation, Medtronic Inc. among others represent the global Pulmonary Heart Valve Replacement ...

Pulmonary valve stenosis can be both congenital (present at birth) or something adults develop later on in life. It can range in severity from mild to severe cases. Often, a person may not know they ...